Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials.
about
High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic ProfileDose escalation with over-dose and under-dose controls in Phase I/II clinical trials.Optimizing drug development in oncology by clinical trial simulation: Why and how?An Escalation for Bivariate Binary Endpoints Controlling the Risk of Overtoxicity (EBE-CRO): Managing Efficacy and Toxicity in Early Oncology Clinical Trials.
P2860
Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Escalation with overdose contr ...... ancer Phase I clinical trials.
@ast
Escalation with overdose contr ...... ancer Phase I clinical trials.
@en
type
label
Escalation with overdose contr ...... ancer Phase I clinical trials.
@ast
Escalation with overdose contr ...... ancer Phase I clinical trials.
@en
prefLabel
Escalation with overdose contr ...... ancer Phase I clinical trials.
@ast
Escalation with overdose contr ...... ancer Phase I clinical trials.
@en
P2093
P2860
P1476
Escalation with overdose contr ...... cancer Phase I clinical trials
@en
P2093
Fadlo R Khuri
Michael Kutner
Ruiyan Luo
Taofeek K Owonikoko
Zhengjia Chen
Zhibo Wang
P2860
P304
P356
10.1016/J.CCT.2014.02.004
P407
P577
2014-02-12T00:00:00Z